SurgeryCeKATUNCT03468738
Investigation of the Transfusion Practices in Surgical Patients in Turkey
An observational study of Surgery and Blood Loss, Surgical, run by Diskapi Teaching and Research Hospital at 61 sites in Turkey (Türkiye).
Trial summary
The aim of this study is to describe the transfusion practices in patients undergoing major surgery in Turkey. The transfusion rates of red blood cells (RBC), fresh frozen plasma (FFP) and platelets; the transfusion predictors and transfusion related patient outcomes are investigated. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Surgery, Blood Loss, Surgical, Blood Loss Anemia
- What is being tested?
- Blood transfusion
- How many people
- 6,481 participants
- Where
- 61 sitesTurkey (Türkiye)
- Study dates
- 2 Apr 2018to 1 Feb 2019
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Patients undergoing major elective surgery in General surgery Orthopedics Urology Transplantation surgery Neurosurgery Gynecology and obstetrics Cardiovascular surgery
Who may be able to join
- Patients undergoing major elective surgery
Who cannot join
- Trauma patients, emergency surgery
Trial locations and contacts
61 sites in 1 country.
61 sites in 1 country
Turkey (Türkiye)61 sites
Acibadem University Mehmet Ali Aydinlar Atakent Hospital
Ankara
Ankara University Cebeci Medical Center
Ankara
Ankara University Ibni Sina Hospital
Ankara
Başkent University Ankara Hospital
Ankara
Gazi University Medical Faculty
Ankara
Hacettepe University Medical Faculty
Ankara
Private Cankaya Hospital
Ankara
Ufuk University Medical Faculty Dr. Ridvan Ege Training and Research Hospital
Ankara
University of Health sciences Ankara Child Health and Diseases Hematology Oncology Training and research Hospital
Ankara
University of Health Sciences Ankara Numune Training and Research Hospital
Ankara
University of Health Sciences Ankara Training and Research Hospital
Ankara
University of Health Sciences Diskapi Yildirim Beyazit Trainig Research Hospital
Ankara
University of Health Sciences Dr Abdurrahman Yurtaslanı Ankara Oncology Training and Research Hospital
Ankara
University of Health Sciences Kecioren Training and Research Hospital
Ankara
University of Health Sciences Turkiye Yuksek Ihtisas Training and Research Hospital
Ankara
University of Health Sciences Yenimahalle Training and Research Hospital
Ankara
University of Health Sciences Zubeyde Hanim Gynecology and Maternity Training and Research Hospital
Ankara
University of Technology and Economics Medical Faculty
Ankara
Akdeniz University Medical Faculty
Antalya
University of Health Sciences Antalya Training and Research Hospital
Antalya
Balikesir University Training and Research Hospital
Balıkesir
Uludağ University Medical Faculty
Bursa
University of Health Sciences Bursa Yuksek Ihtisas Training and Research Hospital
Bursa
Hitit University Corum Erol Olcok Training and Research Hospital
Çorum
Trakya University Medical Faculty
Edirne
Fırat University Medical Faculty
Elâzığ
Erzincan University Mengucek Gazi Training and Research Hospital
Erzincan
Eskisehir Osmangazi University Medical Faculty
Eskişehir
Suleyman Demirel University Medical Faculty
Isparta
Acibadem University Altunizade Hospital
Istanbul
Istanbul Medeniyet University Goztepe Training and Research Hospital
Istanbul
Istanbul University Medical Faculty
Istanbul
Marmara University Pendik Training and Research Hospital
Istanbul
University of Health Sciences Fatih Sultan Mehmet Training and Research Hospital
Istanbul
University of Health Sciences Haydarpasa Numne Training and Research Hospital
Istanbul
University of Health Sciences Istanbul Training and Research Hospital
Istanbul
University of Health Sciences Kanuni Sultan Suleyman Training and Research Hospital
Istanbul
University of Health Sciences Okmeydanı Training and Research Hospital
Istanbul
University of Health Sciences Umraniye Training and Research Hospital
Istanbul
Dokuz Eylul University Medical Faculty
Izmir
University of Health Sciences Bozyaka Training Research Hospital
Izmir
University of Health Sciences İzmir Tepecik Training and Research Hospital
Izmir
Sutcu Imam University Medical Faculty
Kahramanmaraş
Erciyes University Medical Faculty
Kayseri
University of Health Sciences Kayseri Training and Research Hospital
Kayseri
Anadolu Health Center Hospital
Kocaeli
University of Health Sciences Derince Training and Research Hospital
Kocaeli
Necmettin Erbakan University Meram Medical Faculty Center for Health and Research
Konya
Selcuk University Medical Faculty
Konya
University of Health Sciences Konya Training and Research Hospital
Konya
Inonu University Liver Transplantation Institute
Malatya
Manisa Celal Bayar University Medical Faculty Hafsa Sultan Hospital
Manisa
Mersin University Medical Faculty
Mersin
Ordu University Medical Faculty
Ordu
Osmaniye State Hospital
Osmaniye
Ondokuz Mayıs University Medical Faculty
Samsun
Namık Kemal University Medical Faculty
Tekirdağ
Karadeniz Technical University Medical Faculty Farabi Hospital
Trabzon
Tunceli State Hospital
Tunceli
Van Yuzuncuyıl University Medical Faculty Dursun Odabası Center
Van
Bulent Ecevit University Medical Faculty Center for Health and Research
Zonguldak
About this study
The aim of this study is to describe the transfusion practices in patients undergoing major surgery in Turkey. The transfusion rates of red blood cells (RBC), fresh frozen plasma (FFP) and platelets; the transfusion predictors and transfusion related patient outcomes are investigated.
Read the detailed description
Patient Blood Management (PBM) is an evidence based multidisciplinary approach for the care of patients who may need blood transfusion. The aim of PBM is achieving better patient outcomes by focusing on the patients' own blood as a source.
To date PBM is considered "good transfusion practice" and is being implemented in a growing number of countries. The Turkish Society of Anesthesiologists PBM Task Force is working on this subject since 4 years and decided to conduct a study. Before starting a PBM program, the transfusion practices of clinicians working at diverse surgical fields; differences between current transfusion practices and PBM strategies; the areas for improvement and the obstacles that could prevent change could be identified with this study. Data collection will also serve to identify the current situation as a reference and to control the achievement of the PBM's aim: improving clinical outcomes. These data will be refered as The Turkish National Perioperative Transfusion Study (TULIP TS) data.
The aim of this study is to describe the transfusion practices in patients undergoing major surgery in Turkey.
The study evaluates i. The perioperative transfusion rates of RBCs, FFP and platelets. ii. With which reasons the anesthesiologists decide to transfuse a patient (co morbidities of the patients, physiologic transfusion triggers, hemoglobin trigger, uncontrolled bleeding, on request from surgeon etc.).
iii. The relation of transfusion and the patients co-morbidity index, the P POSSUM score and SORT score; anesthesia methods; monitorisation methods (hemodynamic, coagulation); amount of bleeding; type of surgery; type of hospital.
iv. The relation of transfusion and patient outcomes (unanticipated ICU admission, prolonged ICU stay, acute renal failure, thromboembolic events, ischemic events, pulmonary complications, cardiac advers events, infections, acute respiratory distress, infection, all-cause mortality).
- Conditions
- Surgery, Blood Loss, Surgical, Blood Loss Anemia, Blood Transfusion, Anemia, Coagulation Disorder
- Being tested
- Blood transfusion
- Medical subject headings
- Blood Loss, Surgical, Anemia, Hemostatic Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Blood transfusionOther
Transfusion of blood products in the perioperative period in patients undergoing major surgery
What is being measured
The primary outcome is the main question the study is designed to answer.
Preoperative amount of blood products transfused
Preoperative amount of blood products: RBCs,FFP and platelets transfused
Measured: Before surgery at day 0
Intraoperative amount of blood products transfused
Intraoperative amount of blood products: RBC's,FFP and platelets transfused
Measured: During surgery at day 0
Postoperative amount of blood products transfused
Postoperative amount of blood products: RBCs,FFP and platelets transfused
Measured: 24 hours after surgery
Secondary outcomes (17)
Preoperative transfusion indications
The reasons to decide to transfuse (factors determining transfusion) blood products
Measured: Before surgery at day 0
Intraoperative transfusion indications
The reasons to decide to transfuse (factors determining transfusion) blood products
Measured: During surgery at day 1
Postoperative transfusion indications
The reasons to decide to transfuse (factors determining transfusion) blood products
Measured: 24 hours after surgery
Unanticipated ICU admission
Whether the patient had an unanticipated ICU admission
Measured: After surgery at day 1
Prolonged length of stay in ICU
Whether the patient had a prolonged length of stay in ICU
Measured: After surgery at day 2
Acute renal failure
Whether the patient had acute renal failure
Measured: After surgery at day 2
Thromboembolic event
Whether the patient had a thromboembolic event concerning lungs (pulmonary embolism), brain (stroke), gastrointestinal tract, kidneys, or extremities etc.
Measured: After surgery at day 2
Ischemic event
Whether the patient had an ischemic event concerning heart, nervous system,limb, gastrointestinal tract etc.
Measured: After surgery at day 2
Infection
Whether the patient had infection: wound, pneumonia, urinary, sepsis etc.
Measured: After surgery at day 2
Acute respiratory distress
Whether the patient had acute respiratory distress
Measured: After surgery at day 2
Mortality
Whether the patient died: all cause mortality
Measured: after surgery at day 30
Preoperative anemia
Whether the patient had anemia (Hemoglobin male < 13 female < 12 g/dL)
Measured: Before surgery at day 0
Preoperative coagulopathy
Whether the patient had coagulopathy due to disease or drugs
Measured: Before surgery at day 0
Pretransfusion hemoglobin values
The hemoglobin concentration before transfusion
Measured: Before surgery at day 0
Pretransfusion hemoglobin values
The hemoglobin concentration before transfusion
Measured: During surgery at day 1
Pretransfusion hemoglobin values
The hemoglobin concentration before transfusion
Measured: After surgery at day 2
Advers cardiac events
Whether the patient had an advers cardiac event: myocardial infaction; non fatal cardiac arest; arrhytmia; cardiogenic pulmonary edema etc
Measured: After surgery at day 30
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Mar 2018
- Study start2 Apr 2018
- Primary completion1 Feb 2019
- Study completion1 Feb 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (5)Papers the sponsor has linked to this study.
- Other trials for SurgeryStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 6,481 participants (actual)
Sponsor and investigators
- Lead sponsor
- Diskapi Teaching and Research Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- Turkish Society of Anesthesiology and Reanimation
- Responsible party
- Principal investigator, DILEK YAZICIOGLU, Diskapi Teaching and Research Hospital
- Investigators
- Dilek Unal, Assoc Prof, Principal investigator, Netherlands: Ministry of Health, Welfare and Sports
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03468738
- Sponsor's protocol ID
- Dilek Yazıcıoglu Unal
- Acronym
- CeKATU
- Status last verified
- Apr 2018
- First submitted
- 11 Mar 2018
- Last updated
- 25 Apr 2019
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Kotze A, Carter LA, Scally AJ. Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. Br J Anaesth. 2012 Jun;108(6):943-52. doi: 10.1093/bja/aes135.
PubMed 22593128Meier J, Filipescu D, Kozek-Langenecker S, Llau Pitarch J, Mallett S, Martus P, Matot I; ETPOS collaborators. Intraoperative transfusion practices in Europe. Br J Anaesth. 2016 Feb;116(2):255-61. doi: 10.1093/bja/aev456.
PubMed 26787795Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007 Nov 27;116(22):2544-52. doi: 10.1161/CIRCULATIONAHA.107.698977. Epub 2007 Nov 12.
PubMed 17998460Hsieh FY, Bloch DA, Larsen MD. A simple method of sample size calculation for linear and logistic regression. Stat Med. 1998 Jul 30;17(14):1623-34. doi: 10.1002/(sici)1097-0258(19980730)17:143.0.co;2-s.
PubMed 9699234Kalil AC, Mattei J, Florescu DF, Sun J, Kalil RS. Recommendations for the assessment and reporting of multivariable logistic regression in transplantation literature. Am J Transplant. 2010 Jul;10(7):1686-94. doi: 10.1111/j.1600-6143.2010.03141.x.
PubMed 20642690
Study at a glance
From the registry record, last updated by the sponsor on 25 Apr 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Investigation of the Transfusion Practices in Surgical Patients in Turkey
- ClinicalTrials.gov ID
- NCT03468738
- Acronym / sponsor ID
- CeKATU / Dilek Yazıcıoglu Unal
- Conditions
- Surgery, Blood Loss, Surgical, Blood Loss Anemia, Blood Transfusion, Anemia, Coagulation Disorder
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 6,481 participants (actual)
- Lead sponsor
- Diskapi Teaching and Research HospitalUniversity, hospital or other
- Collaborators
- Turkish Society of Anesthesiology and Reanimation
- Study start
- 2 Apr 2018 (actual)
- Primary completion
- 1 Feb 2019 (actual)
- Study completion
- 1 Feb 2019 (actual)
- First posted
- 19 Mar 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to describe the transfusion practices in patients undergoing major surgery in Turkey. The transfusion rates of red blood cells (RBC), fresh frozen plasma (FFP) and platelets; the transfusion predictors and transfusion related patient outcomes are investigated.
Detailed description
Patient Blood Management (PBM) is an evidence based multidisciplinary approach for the care of patients who may need blood transfusion. The aim of PBM is achieving better patient outcomes by focusing on the patients' own blood as a source.
To date PBM is considered "good transfusion practice" and is being implemented in a growing number of countries. The Turkish Society of Anesthesiologists PBM Task Force is working on this subject since 4 years and decided to conduct a study. Before starting a PBM program, the transfusion practices of clinicians working at diverse surgical fields; differences between current transfusion practices and PBM strategies; the areas for improvement and the obstacles that could prevent change could be identified with this study. Data collection will also serve to identify the current situation as a reference and to control the achievement of the PBM's aim: improving clinical outcomes. These data will be refered as The Turkish National Perioperative Transfusion Study (TULIP TS) data.
The aim of this study is to describe the transfusion practices in patients undergoing major surgery in Turkey.
The study evaluates i. The perioperative transfusion rates of RBCs, FFP and platelets. ii. With which reasons the anesthesiologists decide to transfuse a patient (co morbidities of the patients, physiologic transfusion triggers, hemoglobin trigger, uncontrolled bleeding, on request from surgeon etc.).
iii. The relation of transfusion and the patients co-morbidity index, the P POSSUM score and SORT score; anesthesia methods; monitorisation methods (hemodynamic, coagulation); amount of bleeding; type of surgery; type of hospital.
iv. The relation of transfusion and patient outcomes (unanticipated ICU admission, prolonged ICU stay, acute renal failure, thromboembolic events, ischemic events, pulmonary complications, cardiac advers events, infections, acute respiratory distress, infection, all-cause mortality).
Study design
- Observational model
- Other
- Time perspective
- Prospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Patients undergoing major elective surgery in General surgery Orthopedics Urology Transplantation surgery Neurosurgery Gynecology and obstetrics Cardiovascular surgery
Key inclusion criteria (1 listed)
- Patients undergoing major elective surgery
Key exclusion criteria (1 listed)
- Trauma patients, emergency surgery
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Blood transfusionTransfusion of blood products in the perioperative period in patients undergoing major surgery | Other | – |
Primary outcome
Preoperative amount of blood products transfused
Time frame: Before surgery at day 0
Preoperative amount of blood products: RBCs,FFP and platelets transfused
Intraoperative amount of blood products transfused
Time frame: During surgery at day 0
Intraoperative amount of blood products: RBC's,FFP and platelets transfused
Postoperative amount of blood products transfused
Time frame: 24 hours after surgery
Postoperative amount of blood products: RBCs,FFP and platelets transfused
17 secondary outcomes
Preoperative transfusion indications
Time frame: Before surgery at day 0
Intraoperative transfusion indications
Time frame: During surgery at day 1
Postoperative transfusion indications
Time frame: 24 hours after surgery
Unanticipated ICU admission
Time frame: After surgery at day 1
Prolonged length of stay in ICU
Time frame: After surgery at day 2
Acute renal failure
Time frame: After surgery at day 2
Thromboembolic event
Time frame: After surgery at day 2
Ischemic event
Time frame: After surgery at day 2
Infection
Time frame: After surgery at day 2
Acute respiratory distress
Time frame: After surgery at day 2
Mortality
Time frame: after surgery at day 30
Preoperative anemia
Time frame: Before surgery at day 0
Preoperative coagulopathy
Time frame: Before surgery at day 0
Pretransfusion hemoglobin values
Time frame: Before surgery at day 0
Pretransfusion hemoglobin values
Time frame: During surgery at day 1
Pretransfusion hemoglobin values
Time frame: After surgery at day 2
Advers cardiac events
Time frame: After surgery at day 30
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Apr 2019.
- Background: PubMed 22593128Kotze A, Carter LA, Scally AJ. Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. Br J Anaesth. 2012 Jun;108(6):943-52. doi: 10.1093/bja/aes135.
- Background: PubMed 26787795Meier J, Filipescu D, Kozek-Langenecker S, Llau Pitarch J, Mallett S, Martus P, Matot I; ETPOS collaborators. Intraoperative transfusion practices in Europe. Br J Anaesth. 2016 Feb;116(2):255-61. doi: 10.1093/bja/aev456.
- Background: PubMed 17998460Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007 Nov 27;116(22):2544-52. doi: 10.1161/CIRCULATIONAHA.107.698977. Epub 2007 Nov 12.
- Background: PubMed 9699234Hsieh FY, Bloch DA, Larsen MD. A simple method of sample size calculation for linear and logistic regression. Stat Med. 1998 Jul 30;17(14):1623-34. doi: 10.1002/(sici)1097-0258(19980730)17:143.0.co;2-s.
- Background: PubMed 20642690Kalil AC, Mattei J, Florescu DF, Sun J, Kalil RS. Recommendations for the assessment and reporting of multivariable logistic regression in transplantation literature. Am J Transplant. 2010 Jul;10(7):1686-94. doi: 10.1111/j.1600-6143.2010.03141.x.
- Individual participant dataSharing planned: No
Related trials for Surgery
Active, not recruiting
Shockwave™ vs Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Comparison of Efficacy, Safety and Long-Term Outcomes
Common Femoral Artery Stenosis, Calcification; Heart
RecruitingObservational study
Comparison of Hemodynamic Responses During Anesthesia Induction Using Eleveld and Schnider
Spinal (Fusion) Surgery, Total Intravenous Anesthesia
RecruitingPhase 1
Serial Amnioinfusions as Regenerative Therapy for Pulmonary Hypoplasia
Renal Failure Congenital, Congenital Renal Anomaly Nos
RecruitingPhase 2
Proton Spatially Fractionated Radiotherapy or Photon Stereotactic Body Radiotherapy in Combination With Pembrolizumab Before Surgery for the Treatment of Locally Advanced and Radiation-Naive Locoregionally Recurrent Oral Cavity Cancer, OSPRI Trial
Locally Advanced Oral Cavity Squamous Cell Carcinoma, Locally Recurrent Oral Cavity Squamous Cell Carcinoma
RecruitingPhase 2/3
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Dilek Unal, Assoc Prof principal investigator
Netherlands: Ministry of Health, Welfare and Sports
61 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Surgery and Blood Loss, Surgical, run by Diskapi Teaching and Research Hospital at 61 sites in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Apr 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 61 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Preoperative amount of blood products transfused (time frame: Before surgery at day 0). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03468738, which also lists 5 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Apr 2019.